IGFBP1 and metabolic syndrome: Patients with INSR mutation differ biochemically from patients with more common insulin resistance associated with the metabolic syndrome by having high levels of adiponectin, sex-hormone-binding globulin (SHBG), and insulin-like growth factor-binding protein 1 (IGFBP1) [107].